Grant A. McArthur

Publishes on Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management, Cancer Immunotherapy and Biomarkers. 905 papers and 80.5k citations.

PubIndex Score98Top 2%How it's scored

🌟#3 Current Senior Leader in Melanoma and MAPK Pathways

905Publications

80.5kTotal Citations

#3in Melanoma and MAPK Pathways

First publication: 1922First senior author: 2002

Melanoma and MAPK Pathways Cutaneous Melanoma Detection and Management Cancer Immunotherapy and Biomarkers CAR-T cell therapy research Immunotherapy and Immune Responses

Top publicationsby citations

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Paul B. Chapman, Grant A. McArthur, Dirk Schadendorf et al.|New England Journal of Medicine|2011

Cited by 7.7k

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Keith T. Flaherty, Paul B. Chapman, Igor Puzanov et al.|New England Journal of Medicine|2010

Cited by 3.5k

Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma

James Larkin, Antoni Ribas, Paolo A. Ascierto et al.|New England Journal of Medicine|2014

Cited by 2k

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

Gideon Bollag, K. B. Nolop, Peter Hirth et al.|Nature|2010

Cited by 1.8k

<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Fei Su, Jeffrey A. Sosman, Amaya Virós et al.|New England Journal of Medicine|2012

Cited by 1k